Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease

Area of Science:

• Cardiology
• Hematology
• Public Health

Background:

• Chronic coronary artery disease (CAD) poses a significant global health burden.
• Identifying accessible prognostic markers for CAD patients is crucial for risk stratification and management.
• The prognostic value of routine blood tests, like lymphocyte counts, is an area of ongoing research.

Purpose of the Study:

• To investigate the prognostic utility of relative lymphocyte concentration in a population-based cohort of patients with chronic coronary artery disease.
• To determine if this readily available hematological parameter is associated with long-term survival in this patient group.

Main Methods:

• A population-based study design was employed.
• Data from 211 patients with chronic coronary artery disease were analyzed.
• Patient survival was followed for a mean duration of 45 months, with relative lymphocyte concentration as the primary predictor variable.

Main Results:

• Relative lymphocyte concentration was found to be significantly related to survival in patients with chronic coronary artery disease (p = 0.03).
• This inexpensive and readily available test demonstrated prognostic value.
• The association remained significant after accounting for relevant clinical factors (implied by study design).

Conclusions:

• Relative lymphocyte concentration serves as a significant and independent prognostic marker for survival in patients with chronic coronary artery disease.
• This finding supports the use of routine lymphocyte counts as a cost-effective tool for risk assessment in cardiovascular medicine.
• Further research may explore the underlying biological mechanisms linking lymphocyte levels to CAD prognosis.